EXCHANGE TRADED CONCEPTS, LLC
Position in KRYS — Krystal Biotech, Inc.
CIK 1457320
OKLAHOMA CITY, OK
Position in KRYS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$265,372
+$87,649 QoQ
Shares Held
714
+3.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#293
of 419 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 52%
Shared 0%
None 48%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EXCHANGE TRADED CONCEPTS, LLC holds $67,738,617 across 34 Biotechnology names. KRYS ranks #26 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
276,954 | $9,801,401 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,357 | $7,628,281 | |
| 3 | INVA |
Innoviva, Inc.
|
164,758 | $3,741,654 | |
| 4 | MANE |
Veradermics, Inc
|
30,168 | $3,708,853 | |
| 5 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
358,783 | $3,555,539 | |
| 6 | KLRA |
Kailera Therapeutics, Inc.
|
152,501 | $3,359,597 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
87,891 | $3,200,111 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
81,186 | $3,167,065 |
All Filings in KRYS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $265,372 | 714 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $177,723 | 688 | Shares | Other | 2026-04-15 | |
| 2025-12-31 | $228,295 | 926 | Shares | Other | 2026-01-14 | |
| 2025-09-30 | $87,558 | 496 | Shares | Other | 2025-10-14 | |
| No filing history on record for this holder in this stock. | ||||||